ALIGOS THERAPEUTICS INC (ALGS) Stock Earnings & Estimates
NASDAQ:ALGS - US01626L2043 - Common Stock
11.33 USD
+0.35 (+3.19%)
10.62 USD
-0.71 (-6.27%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 13.91M 219.04% | 15.529M 11.64% | 3.945M -74.60% | 2.244M -43.12% | 2.89M 28.79% | 1.666M -42.35% | 138.72M 8,226.53% | 289.93M 109.00% | 467.99M 61.41% | 659.8M 40.99% | 875.35M 32.67% | |
| EBITDA YoY % growth | -95.27M 23.97% | -80.768M 15.22% | -83.927M -3.91% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -97.58M 23.96% | -82.327M 15.63% | -84.954M -3.19% | -91.024M -7.14% | -103.62M -13.84% | -119.197M -15.03% | 2.395M 102.01% | 156.89M 6,450.73% | 313.92M 100.09% | 481.16M 53.27% | 671.92M 39.65% | |
| Operating Margin | -701.51% | -530.15% | -2,153.46% | -4,056.32% | -3,585.48% | -7,154.69% | 1.73% | 54.11% | 67.08% | 72.93% | 76.76% | |
| EPS YoY % growth | -56.50 29.38% | -39.75 29.65% | -11.17 71.90% | -8.77 21.51% | -7.66 12.66% | -7.09 7.46% | 1.16 116.41% | 11.51 889.91% | 19.24 67.17% | 21.61 12.30% | 29.89 38.31% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.23 27.32% | -2.33 31.52% | -2.22 -5.14% | -2.19 -43.00% | -2.25 -0.80% | -2.30 1.20% |
| Revenue Q2Q % growth | 441.997K -65.17% | 441.997K -29.73% | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | N/A | N/A | -25.194M -32.26% | -26.826M | -28.356M | -29.988M |
| EBIT Q2Q % growth | -22.901M -13.76% | -24.202M -47.91% | -25.701M -33.56% | -26.648M -20.85% | -27.545M -20.28% | -28.3M -16.94% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.53 -291.25% | -2.41 | 0.88 | 36.53% |
| Q1 2025 Q2Q % growth | -2.11 61.64% | -2.85 | 0.74 | 26.03% |
| Q4 2024 Q2Q % growth | -3.40 38.18% | -2.55 | -0.85 | -33.51% |
| Q3 2024 Q2Q % growth | -3.07 70.05% | -2.20 | -0.87 | -39.56% |
| Q2 2024 Q2Q % growth | 0.80 107.44% | -4.08 | 4.88 | 119.61% |
| Q1 2024 Q2Q % growth | -5.50 58.49% | -4.85 | -0.66 | -13.52% |
| Q4 2023 Q2Q % growth | -5.50 56.86% | -6.89 | 1.38 | 20.12% |
| Q3 2023 Q2Q % growth | -10.25 6.82% | -12.11 | 1.86 | 15.38% |
| Q2 2023 Q2Q % growth | -10.75 8.51% | -12.62 | 1.87 | 14.83% |
| Q1 2023 Q2Q % growth | -13.25 36.90% | -12.37 | -0.88 | -7.14% |
| Q4 2022 Q2Q % growth | -12.75 42.70% | -12.04 | -0.71 | -5.93% |
| Q3 2022 Q2Q % growth | -11.00 43.59% | -14.79 | 3.79 | 25.63% |
| Q2 2022 Q2Q % growth | -11.75 40.51% | -17.00 | 5.25 | 30.88% |
| Q1 2022 Q2Q % growth | -21.00 -13.51% | -18.55 | -2.45 | -13.20% |
| Q4 2021 Q2Q % growth | -22.25 18.35% | -21.11 | -1.14 | -5.38% |
| Q3 2021 Q2Q % growth | -19.50 92.91% | -20.76 | 1.26 | 6.06% |
| Q2 2021 Q2Q % growth | -19.75 | -20.57 | 0.82 | 3.99% |
| Q1 2021 Q2Q % growth | -18.50 | -22.95 | 4.45 | 19.39% |
| Q4 2020 Q2Q % growth | -27.25 | -21.04 | -6.21 | -29.53% |
| Q3 2020 Q2Q % growth | -275.00 | -19.89 | -255.11 | -1,282.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 965K -9.05% | 441.997K | 523.003K | 118.33% |
| Q1 2025 Q2Q % growth | 311K -68.46% | 339.997K | -28.997K | -8.53% |
| Q4 2024 Q2Q % growth | 629K -68.69% | 441.997K | 187.003K | 42.31% |
| Q3 2024 Q2Q % growth | 1.269M -60.82% | 339.997K | 929.003K | 273.24% |
| Q2 2024 Q2Q % growth | 1.061M -84.59% | 1.061M | % | |
| Q1 2024 Q2Q % growth | 986K -63.79% | 986K | % | |
| Q4 2023 Q2Q % growth | 2.009M -43.25% | 1.632M | 377K | 23.10% |
| Q3 2023 Q2Q % growth | 3.239M -21.19% | 2.55M | 689K | 27.02% |
| Q2 2023 Q2Q % growth | 6.886M 86.61% | 6.886M | % | |
| Q1 2023 Q2Q % growth | 2.723M 5.95% | 2.723M | % | |
| Q4 2022 Q2Q % growth | 3.54M 856.76% | 1.754M | 1.786M | 101.82% |
| Q3 2022 Q2Q % growth | 4.11M 166.88% | 765K | 3.345M | 437.25% |
| Q2 2022 Q2Q % growth | 3.69M 138.06% | 3.69M | % | |
| Q1 2022 Q2Q % growth | 2.57M 182.42% | 2.57M | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -0.78% | 11.36% | 11.48% |
| Revenue | 0% | -13.33% | 17.67% | 2.09% |